Pier Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-76,066
| Closed | -$5.02M | – | 116 |
|
|
2023
Q1 | $5.02M | Buy |
76,066
+849
| +1% | +$56K | 0.76% | 69 |
|
|
2022
Q4 | $3.89M | Buy |
75,217
+19,833
| +36% | +$1.03M | 0.64% | 77 |
|
|
2022
Q3 | $3.78M | Sell |
55,384
-74,956
| -58% | -$5.12M | 0.65% | 75 |
|
|
2022
Q2 | $5.89M | Buy |
130,340
+132
| +0.1% | +$5.97K | 1.01% | 56 |
|
|
2022
Q1 | $6.62M | Sell |
130,208
-91,693
| -41% | -$4.66M | 0.84% | 71 |
|
|
2021
Q4 | $10.5M | Buy |
221,901
+65,870
| +42% | +$3.11M | 1.11% | 44 |
|
|
2021
Q3 | $5.14M | Buy |
+156,031
| New | +$5.14M | 0.53% | 91 |
|